At the same time, inhibition of HRH3 inhibited the metastasis of HCC cells, further supporting the functional role of HRH3 in promoting the metastasis of malignant tumors, which indicates that increased HRH3 levels can be a potential prognostic marker for HCC patients (Yu et al., 2019). The gene discussed is HRH3; the disease is cancer.